Complementary Medicines Implementation Reference Group
Membership and terms of reference
December 2006
The TGA established the Complementary Medicines Implementation Reference Group to provide advice on and oversee the implementation of the Government Response.
Membership
- Dr Michael Bollen AM, Principal, BMP Healthcare Consulting Pty Ltd (Chair)
- Professor Alan Bensoussan, Director, Centre for Complementary Medicine Research and Head, Chinese Medicine Unit, University of Western Sydney. Expert Panel Members for Chinese Medicines on the Complementary Medicine Evaluation Committee (CMEC);
- Dr David Briggs, Director, Office of Complementary Medicines, Therapeutic Goods Administration;
- Mr Ron Geiger, Chairman, Natural Products New Zealand (NPNZ), and Managing Director, Alaron Products Limited, NZ;
- Dr Tony Lewis, Executive Director, Complementary Healthcare Council of Australia (CHC);
- Professor Stephen Myers, Director, Australian Centre for Complementary Medicine Education and Research (ACCMER). Member, CMEC;
- Ms Juliet Seifert, Executive Director, Australian Self-Medication Industry Inc (ASMI);
- Ms Viola Korczak, Health Policy Officer, Australian Consumers Association;
- Ms Geraldine Robertson, Consumers' Health Forum.
Terms of reference
The Terms of Reference for the Complementary Medicines Implementation Reference Group are to:
- Provide advice on the development of a plan and timetable for implementing the Government Response to the recommendations of the Expert Committee on Complementary Medicines in the Health System;
- Monitor progress on the implementation of the Government Response; and
- Assist in the development of a report reviewing progress 12 months after commencement of the implementation plan.